Yo_octubre_2018.jpg_thumb90

Mario Francis Rivera Meza

Profesor Asociado

Universidad de Chile

Santiago, Chile

Líneas de Investigación


Alcoholism; Gene Therapy; Pharmacology; Alcohol intake; Drug Dependence; Gene Therapy of Alcoholism; Mechanisms of Alcohol Addiction; Vectors for Gene Therapy; Farmacologia (Neurofarmacologia); Neuroquimica; Neurociencias; Alcoholism, animal models and interventions in humans; Mechanism of alcohol actions; Gene delivery and phage display libraries

Educación

  •  Químico Farmacéutico, UNIVERSIDAD DE CHILE. Chile, 1998
  •  Doctorado en Farmacología, UNIVERSIDAD DE CHILE. Chile, 2009
  •  Diplomado en Innovación y Docencia Universitaria, UNIVERSIDAD DE CHILE. Chile, 2019
  •  Análisis Instrumental Orgánico , UNIVERSIDAD DE CHILE. Chile, 2025

Experiencia Académica

  •   Profesor Asociado Full Time

    UNIVERSIDAD DE CHILE

    Ciencias Químicas y Farmacéuticas

    Santiago, Chile

    2015 - A la fecha

  •   Investigador Postdoctoral Full Time

    UNIVERSIDAD DE CHILE

    Medicina

    Santiago, Chile

    2010 - 2015

Experiencia Profesional

  •   Director Tecnico Full Time

    Farmacias Cruz Verde

    Santiago, Chile

    1999 - 2004

Formación de Capital Humano


no info


Difusión y Transferencia


No info


Premios y Distinciones

  •   Mejor Profesor Pregrado

    UNIVERSIDAD DE CHILE

    Chile, 2025

    Reconocimiento al mejor alumno de pregrado en la Facultad de cienciasQuímicas y Farmacéuticas

  •   Premio Jorge Mardones Restat

    SOCIEDAD DE FARMACOLOGIA DE CHILE

    Chile, 2009

    Premio entregado a la mejor investigación en Farmacología por estudiantes de posgrado.


 

Article (33)

Fenofibrate restores glutamatergic and dopaminergic homeostasis in the nucleus accumbens and reduces alcohol relapse in rats
Blockade of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels reduces alcohol-induced dopamine release and reward in rats
Early-life exposure to sex hormones promotes voluntary ethanol intake in adulthood. A vulnerability factor to drug addiction.
Pharmacological activators of ALDH2: A new strategy for the treatment of alcohol use disorders
ALDH2 inhibition by lead and ethanol elicits redox imbalance and mitochondrial dysfunction in SH-SY5Y human neuroblastoma cell line: Reversion by Alda-1
Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies
Overexpression of wild type glycine alpha 1 subunit rescues ethanol sensitivity in accumbal receptors and reduces binge drinking in mice
Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the α482 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine
Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibition
The administration of Alda-1, an activator of ALDH2, inhibits relapse-like ethanol intake in female alcohol-preferring UChB rats
Gene knockdown of HCN2 ion channels in the ventral tegmental area reduces ethanol consumption in alcohol preferring rats
UFR2709, an Antagonist of Nicotinic Acetylcholine Receptors, Delays the Acquisition and Reduces Long-Term Ethanol Intake in Alcohol-Preferring UChB Bibulous Rats
Fenofibrate -a PPAR alpha agonist- increases alcohol dehydrogenase levels in the liver: implications for its possible use as an ethanol-aversive drug
Activation of mitochondrial aldehyde dehydrogenase (ALDH2) by ALDA-1 reduces both the acquisition and maintenance of ethanol intake in rats: A dual mechanism?
Molecular modeling of salsolinol, a full G(i) protein agonist of the mu-opioid receptor, within the receptor binding site
Molecular modeling of salsolinol, a full Gi protein agonist of the μ-opioid receptor, within the receptor binding site
Silencing brain catalase expression reduces ethanol intake in developmentally-lead-exposed rats
UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats
Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors, decreases ethanol consumption in alcohol-preferring UChB rats
Acquisition, Maintenance and Relapse-Like Alcohol Drinking: Lessons from the UChB Rat Line
Fenofibrate Administration Reduces Alcohol and Saccharin Intake in Rats: Possible Effects at Peripheral and Central Levels
Racemic Salsolinol and its Enantiomers Act as Agonists of the mu-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway
(R)-Salsolinol, a product of ethanol metabolism, stereospecifically induces behavioral sensitization and leads to excessive alcohol intake
Beyond the "First Hit": Marked Inhibition by N-Acetyl Cysteine of Chronic Ethanol Intake But Not of Early Ethanol Intake. Parallel Effects on Ethanol-Induced Saccharin Motivation
Long-term inhibition of ethanol intake by the administration of an aldehyde dehydrogenase-2 (ALDH2)-coding lentiviral vector into the ventral tegmental area of rats
Overexpression of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels into the Ventral Tegmental Area Increases the Rewarding Effects of Ethanol in UChB Drinking Rats
Salsolinol, free of isosalsolinol, exerts ethanol-like motivational/sensitization effects leading to increases in ethanol intake
The Alcohol Deprivation Effect: Marked Inhibition by Anticatalase Gene Administration into the Ventral Tegmental Area in Rats
Reduction of Ethanol Consumption in Alcohol-Preferring Rats by Dual Expression Gene Transfer
Reward and Relapse: Complete Gene-Induced Dissociation in an Animal Model of Alcohol Dependence
Acetaldehyde Burst Protection of ADH1B*2 Against Alcoholism: An Additional Hormesis Protection Against Esophageal Cancers Following Alcohol Consumption?
Ethanol as a Prodrug: Brain Metabolism of Ethanol Mediates its Reinforcing Effects
Mechanism of protection against alcoholism by an alcohol dehydrogenase polymorphism: development of an animal model

BookSection (1)

The Hyperpolarization-Activated Cyclic Nucleotide-Gated Ion Channels in the Rewarding Effects of Ethanol

Letter (1)

PPAR? agonists reduce alcohol drinking: Do they act in the brain or in the liver?

Proyecto (1)

A common mechanism for alcohol- and nicotine-use disorders: translational options

Review (3)

Gene and cell therapy on the acquisition and relapse-like binge drinking in a model of alcoholism: translational options
The "First Hit" Toward Alcohol Reinforcement: Role of Ethanol Metabolites
Gene specific modifications unravel ethanol and acetaldehyde actions
2
Gerald Zapata

Profesor Asociado

Química Inorgánica y Analítica

Universidad de Chile

Santiago, Chile

8
Mario Herrera-Marschitz

Profesor titular

Mol. & Clin. Pharmacology

UNIVERSIDAD DE CHILE, FACULTAD DE MEDICINA, PROGRAMA FARMACOLOGIA MOLECULAR & CLINICA, ICBM

Santiago, Chile

6
Paola Morales

Profesor Asociado

Programa Farmacología Molecular & Clínica, ICBM,

Universidad de Chile

Santiago, Chile

1
Ricardo Delgado

Profesor Adjunto

Biología

UNIVERSIDAD DE CHILE, FACULTAD DE CIENCIAS, DEPARTAMENTO DE BIOLOGIA

Santiago, Chile

8
Eduardo Karahanian

Académico Investigador

Facultad de Ciencias de la Salud

Universidad Autónoma de Chile

Santiago, Chile

2
Fernando Ezquer

Full Professor

Center for Regenerative Medicine

Universidad del Desarrollo

Santiago, Chile

1
Patricio Iturriaga

Profesor Asociado A

Ciencias Quimicas y Recursos Naturales

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

2
Bruce Cassels

Profesor Titular

Departamento de Química

UNIVERSIDAD DE CHILE, FACULTAD DE CIENCIAS, DEPARTAMENTO DE QUÍMICA

Santiago, Chile

1
Eduardo Ezquer

Director/Full Professor

Centro de Medicina Regenerativa

UNIVERSIDAD DEL DESARROLLO, FACULTAD DE MEDICINA, INSTITUTO DE CIENCIAS

Santiago, Chile

11
María Quintanilla

PROFESOR ASOCIADO

FARMACOLOGÍA MOLECULAR Y CLÍNICA

UNIVERSIDAD DE CHILE, FACULLTAD DE MEDICINA, INSTITUTO DE CIENCIAS BIOMÉDICAS, PROGRAMA DE FARMACOLOGÍA MOLECULAR Y CLÍNICA

Santiago, Chile

4
Ramón Sotomayor

Full Professor

Institute of Physiology

UNIVERSIDAD DE VALPARAÍSO, FACULTAD DE CIENCIAS, DEPARTAMENTO DE FISIOLOGÍA

Valparaíso, Chile

11
Yedy Israel

Profesor Titular

Farmacologia Molecular y Clinica

UNIVERSIDAD DE CHILE, FACULTAD DE CS QUIMICAS Y FARMACÉUTICAS, LAB. FARMACOTERAPIA GÉNICA

Santiago, Chile

39
Mario Rivera

Profesor Asociado

Química Farmacológica y Toxicológica

Universidad de Chile

Santiago, Chile

9
Eduardo Karahanian

Professor

INSTITUTO DE CIENCIAS BIOMEDICAS

UNIVERSIDAD AUTONOMA DE CHILE

Santiago, Chile

1
Mabel Catalán

Profesora Asistente

Instituto de Ciencias Biomédicas

Universidad de Chile

Santiago, Chile

1
Renatto Anfossi

Jefe de Investigación

Departamento de Investigación

Hospital Regional Libertador Bernardo O'Higgins

Rancagua, Chile

1
Georgina Renard

Associate professor - Directora CIBAP

School of Medicine

Universidad de Santiago de Chile

Santiago, Chile

1
Christian Castillo

Profesor Asistente

Instituto Ciencias Biomédicas

Universidad de Chile

Santiago, Chile

2
Marianne Buscaglia

Postdoc

Genética Molecular y Microbiología

Centro de Modelamiento Matemático

Santiago, Chile

2
Katia Fernández

Académico - Profesor Asociado

Facultad de Salud y Odontología

Universidad Diego Portales

Santiago, Chile

1
Juan González

Profesor Investigador

Departamento de Física y Química

Universidad Autónoma de Chile

Talca, Chile

4
Pablo Berríos

Asistente de investigación

Universidad del Desarrollo

Santiago, Chile

1
Fabiola González

Investigadora Postdoctoral

Universidad de Chile

Santiago, Chile

1
Gabriel Galvez

Asistente de investigacion

Escuela de ingenieria

Universidad de O'Higgins

RAncagua, Chile

1
Daniela Guzmán

Docente

Escuela de Química y Farmacia

Universidad Andrés Bello

Santiago, Chile